1. Assuring quality of drugs by monitoring impurities☆
2. Pharmaceutical impurities—A mini-review
3. International Conference on Harmonization (ICH): Guidance for Industry Q3A - Impurities in New Drug Substances; Rev. 2, 2008, U.S. Department of Health and Human Services: FDA, CDER, CBER,http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073385.pdf(10/18/2016).
4. International Conference on Harmonization (ICH): Guidance for Industry Q3B - Impurities in New Drug Products; Rev. 2, 2006, U.S. Department of Health and Human Services: FDA, CDER, CBER,http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073389.pdf(10/18/2016).